ABCB1 and cancer: To determine whether ITZ was able to overcome DTX resistance unrelated to ABCB1 upregulation, we analyzed the DTX sensitivity data from the Genomic of Drug Sensitivity in Cancer project platform (GDSC1 dataset) to identify cell lines with substantial intrinsic DTX resistance (IC50 > 0.1 μM; Figure 3C).